Unadjusted logistic regression | Adjusted logistic regression⁑ | ||||||||
---|---|---|---|---|---|---|---|---|---|
Patient Characteristics | Patients without HAI | Patientswith HAI | 95% | CI | 95% | CI | |||
n = 987 | n = 115 | OR | lower | upper | OR | lower | upper | p-value | |
Sex | |||||||||
female, n (%) | 498 (50.5) | 57 (49.5) | 1.04 | 0.70 | 1.52 | ||||
Age, years | |||||||||
median [IQR] | 71 [56 82] | 71 [57 82] | 1.01 | 0.99 | 1.01 | ||||
Age classes, n (%) | |||||||||
15–64 years | 345 (35.0) | 39 (33.9) | Ref | ||||||
0–1 years | 29 (2.9) | 3 (2.6) | 0.92 | 0.27 | 3.14 | ||||
2–14 years | 15 (1.5) | 0 (0.0) | – | – | – | ||||
> 64 years | 598 (60.6) | 73 (63.5) | 1.08 | 0.72 | 1.63 | ||||
McCabe Score, n (%) | |||||||||
Non-fatal disease | 594 (61.0) | 30 (27.0) | Ref | ||||||
Ultimately fatal disease | 233 (24.0) | 35 (31.5) | 2.97 | 1.78 | 4.96 | ||||
Rapidly fatal disease | 146 (15.0) | 46 (41.5) | 6.23 | 3.80 | 10.22 | 2.63 | 1.59 | 4.36 | 0.001 |
Medical Devices, n (%) | |||||||||
Presence of PVC | 674 (68.3) | 81 (71.7) | 1.18 | 0.76 | 1.81 | 2.80 | 1.57 | 4.99 | 0.001 |
Presence of urinary catheter | 346 (35.2) | 73 (64.6) | 3.36 | 2.24 | 5.05 | 1.78 | 1.10 | 2.90 | 0.019 |
Presence of CVC | 120 (12.2) | 52 (45.2) | 5.96 | 3.94 | 9.02 | 3.59 | 1.98 | 6.51 | < 0.001 |
Presence of MV | 18 (1.8) | 17 (14.9) | 9.43 | 4.71 | 18.90 | 4.13 | 1.68 | 10.19 | 0.002 |
Surgery, n (%) | |||||||||
None | 688 (69.9) | 75 (65.2) | Ref | ||||||
Non-NHSN | 148 (15.0) | 19 (16.5) | 1.18 | 0.69 | 2.01 | ||||
NHSN | 149 (15.1) | 21 (18.3) | 1.29 | 0.77 | 2.16 | ||||
Time at risk*, days | |||||||||
median [IQR] | 6 [2 13] | 15 [9 29] | 1.01 | 1.003 | 1.011 | ||||
Time at risk, n (%) | |||||||||
> 6 days | 472 (47.8) | 103 (89.6) | 9.37 | 5.08 | 17.24 | 9.38 | 4.87 | 18.08 | < 0.001 |
Year of the survey, n (%) | |||||||||
2016 | 478 (48.4) | 52 (45.2) | Ref | ||||||
2018 | 509 (51.6) | 63 (54.8) | 1.14 | 0.77 | 1.68 |